Population-level trends in attention-deficit/hyperactivity disorder medication prescribing
Myran D, MacDonald-Spracklin R, Busa G, Talarico R, Finkelstein Y. JAMA Netw Open. 2025; 8(12): e2548532.
Myran D, MacDonald-Spracklin R, Busa G, Talarico R, Finkelstein Y. JAMA Netw Open. 2025; 8(12): e2548532.
Myran DT, Pugliese M, McDonald AJ, Xiao J, Fischer B, Finkelstein Y, Tanuseputro P, Firth J, Pakpour A, Hsu CW, Chang WC, Solmi M. JAMA Netw Open. 2025; 8(2):e2457852.
Myran DT, Pugliese M, Harrison LD, Solmi M, Anderson KK, Fiedorowicz JG, Finkelstein Y, Manuel D, Taljaard M, Webber C, Tanuseputro P. JAMA Network Open. 2025; 8(2):e2457868.
Myran DT, Gaudreault A, McCarthy SDS, Pugliese M, Tanuseputro P, Finkelstein Y. Am J Emerg Med. 2023; Dec 1 [Epub ahead of print].
Myran DT, Harrison LD, Pugliese M, Solmi M, Anderson KK, Fiedorowicz JG, Perlman CM, Webber C, Finkelstein Y, Tanuseputro P. JAMA Psych. 2023; Sep 27 [Epub ahead of print].
Myran DT, Cantor N, Finkelstein Y, Pugliese M, Guttmann A, Jesseman R, Tanuseputro P. JAMA Netw Open. 2022; 5(1):e2142521. Epub 2022 Jan 7.
Sander B, Finkelstein Y, Lu H, Nagamuthu C, Graves E, Ramsay LC, Kwong JC, Schuh S. PLoS One. 2021; 16(12):e0260809. Epub 2021 Dec 2.
Fong I, Zhu J, Finkelstein Y, To T. ERJ Open Res. 2021; 7:00944-2020. Epub 2021 Mar 15.
Gilley M, Sivilotti MLA, Juurlink DN, Macdonald E, Yao Z, Finkelstein Y. J Clin Toxicol (Phila). 2020; 58(7):711-5. Epub 2019 Nov 24.
Glockler-Lauf SD, Finkelstein Y, Zhu J, Feldman LY, To T. J Pediatr. 2019; 209:176-82.e4. Epub 2019 Mar 21.